Global CRISPR and Cas Genes Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Global CRISPR and Cas Genes Market report published by EXTENT RESEARCH exemplifies the market growth driving factors such as changing market dynamics, developmental trends, product launches, market sustainable strategies, and latest opportunities. The report also encompasses the market threats and business growth restraints to keep the readers updated on the market growth and status on the global platform. This market study owns the responsibility to offer in-depth business breakdown structure, changing market statistics, and competitive market aspects. Nevertheless, the pre- and post-COVID-19 market analysis is well sketched in the report to touch upon each and every market detail whether microscopic or macroscopic so as to enlighten the readers with the market practicalities and opportunities.

Data provided by Extent Research. Source: https://www.extentresearch.com/crispr-and-cas-genes-market

In the global CRISPR and Cas Genes report, the competitive section has all the information related to the company finances, growth aspects, business strategies, and future possibilities encrypted through the comprehensive company profiling. Company profiling is strategy used to gain better insight on to the company growth opportunities & challenges and economic stability in the long run. Some of the key market players dominating the global CRISPR and Cas Genes market mentioned in the report is: Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, Merck, Integrated DNA Technologies, Inc., Transposagen Biopharmaceuticals, Inc., OriGene Technologies, Inc., New England Biolabs, Horizon Discovery Group Co., Cellecta, Inc., Agilent Technologies, Applied StemCell, Inc., .

In terms of geographical analysis, this report reveals the future of the CRISPR and Cas Genes market in different regions owing to its supply & demand ratio, sales & marketing, product demand, and market developmental trends. Some of the regions proving profitable for the market growth include: by Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

The global CRISPR and Cas Genes market report is here to shed light on the market competitive landscape, geographical distribution, market analysis & statistics, sales, distribution, and opportunities to systematically comprehend the complete market study.

Segmentation of the Global CRISPR and Cas Genes Market:

Product type

Vector-based Cas, DNA-free Cas,

by Application

Genome Engineering, Disease Models, Others,

Why Purchase Global CRISPR and Cas Genes Market report?

Analysis on market dynamics, company profiling, and regional distribution
CRISPR and Cas Genes market study focuses on the key business strategies and growth targets
Study on changing market behaviors related to latest opportunities & challenges
Global CRISPR and Cas Genes market study clearly explains the market statistics and business breakdown structure
Availability of market customization and 24*7 services to offer complete market analysis

Report Scope and Market Segmentation

ATTRIBUTES	Global CRISPR and Cas Genes Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global CRISPR and Cas Genes Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CRISPR and Cas Genes Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Vector-based Cas
        1.2.3 DNA-free Cas
    1.3 Market by Application
        1.3.1 Global CRISPR and Cas Genes Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Genome Engineering
        1.3.3 Disease Models
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CRISPR and Cas Genes Market Perspective (2017-2035)
    2.2 CRISPR and Cas Genes Growth Trends by Region
        2.2.1 CRISPR and Cas Genes Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 CRISPR and Cas Genes Historic Market Size by Region (2017-2022)
        2.2.3 CRISPR and Cas Genes Forecasted Market Size by Region (2023-2035)
    2.3 CRISPR and Cas Genes Market Dynamics
        2.3.1 CRISPR and Cas Genes Industry Trends
        2.3.2 CRISPR and Cas Genes Market Drivers
        2.3.3 CRISPR and Cas Genes Market Challenges
        2.3.4 CRISPR and Cas Genes Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CRISPR and Cas Genes Players by Revenue
        3.1.1 Global Top CRISPR and Cas Genes Players by Revenue (2017-2022)
        3.1.2 Global CRISPR and Cas Genes Revenue Market Share by Players (2017-2022)
    3.2 Global CRISPR and Cas Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CRISPR and Cas Genes Revenue
    3.4 Global CRISPR and Cas Genes Market Concentration Ratio
        3.4.1 Global CRISPR and Cas Genes Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CRISPR and Cas Genes Revenue in 2021
    3.5 CRISPR and Cas Genes Key Players Head office and Area Served
    3.6 Key Players CRISPR and Cas Genes Product Solution and Service
    3.7 Date of Enter into CRISPR and Cas Genes Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and Cas Genes Breakdown Data by Type
    4.1 Global CRISPR and Cas Genes Historic Market Size by Type (2017-2022)
    4.2 Global CRISPR and Cas Genes Forecasted Market Size by Type (2023-2035)
5 CRISPR and Cas Genes Breakdown Data by Application
    5.1 Global CRISPR and Cas Genes Historic Market Size by Application (2017-2022)
    5.2 Global CRISPR and Cas Genes Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America CRISPR and Cas Genes Market Size (2017-2035)
    6.2 North America CRISPR and Cas Genes Market Size by Type
        6.2.1 North America CRISPR and Cas Genes Market Size by Type (2017-2022)
        6.2.2 North America CRISPR and Cas Genes Market Size by Type (2023-2035)
        6.2.3 North America CRISPR and Cas Genes Market Share by Type (2017-2035)
    6.3 North America CRISPR and Cas Genes Market Size by Application
        6.3.1 North America CRISPR and Cas Genes Market Size by Application (2017-2022)
        6.3.2 North America CRISPR and Cas Genes Market Size by Application (2023-2035)
        6.3.3 North America CRISPR and Cas Genes Market Share by Application (2017-2035)
    6.4 North America CRISPR and Cas Genes Market Size by Country
        6.4.1 North America CRISPR and Cas Genes Market Size by Country (2017-2022)
        6.4.2 North America CRISPR and Cas Genes Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe CRISPR and Cas Genes Market Size (2017-2035)
    7.2 Europe CRISPR and Cas Genes Market Size by Type
        7.2.1 Europe CRISPR and Cas Genes Market Size by Type (2017-2022)
        7.2.2 Europe CRISPR and Cas Genes Market Size by Type (2023-2035)
        7.2.3 Europe CRISPR and Cas Genes Market Share by Type (2017-2035)
    7.3 Europe CRISPR and Cas Genes Market Size by Application
        7.3.1 Europe CRISPR and Cas Genes Market Size by Application (2017-2022)
        7.3.2 Europe CRISPR and Cas Genes Market Size by Application (2023-2035)
        7.3.3 Europe CRISPR and Cas Genes Market Share by Application (2017-2035)
    7.4 Europe CRISPR and Cas Genes Market Size by Country
        7.4.1 Europe CRISPR and Cas Genes Market Size by Country (2017-2022)
        7.4.2 Europe CRISPR and Cas Genes Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CRISPR and Cas Genes Market Size (2017-2035)
    8.2 Asia-Pacific CRISPR and Cas Genes Market Size by Type
        8.2.1 Asia-Pacific CRISPR and Cas Genes Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific CRISPR and Cas Genes Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific CRISPR and Cas Genes Market Share by Type (2017-2035)
    8.3 Asia-Pacific CRISPR and Cas Genes Market Size by Application
        8.3.1 Asia-Pacific CRISPR and Cas Genes Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific CRISPR and Cas Genes Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific CRISPR and Cas Genes Market Share by Application (2017-2035)
    8.4 Asia-Pacific CRISPR and Cas Genes Market Size by Region
        8.4.1 Asia-Pacific CRISPR and Cas Genes Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific CRISPR and Cas Genes Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America CRISPR and Cas Genes Market Size (2017-2035)
    9.2 Latin America CRISPR and Cas Genes Market Size by Type
        9.2.1 Latin America CRISPR and Cas Genes Market Size by Type (2017-2022)
        9.2.2 Latin America CRISPR and Cas Genes Market Size by Type (2023-2035)
        9.2.3 Latin America CRISPR and Cas Genes Market Share by Type (2017-2035)
    9.3 Latin America CRISPR and Cas Genes Market Size by Application
        9.3.1 Latin America CRISPR and Cas Genes Market Size by Application (2017-2022)
        9.3.2 Latin America CRISPR and Cas Genes Market Size by Application (2023-2035)
        9.3.3 Latin America CRISPR and Cas Genes Market Share by Application (2017-2035)
    9.4 Latin America CRISPR and Cas Genes Market Size by Country
        9.4.1 Latin America CRISPR and Cas Genes Market Size by Country (2017-2022)
        9.4.2 Latin America CRISPR and Cas Genes Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CRISPR and Cas Genes Market Size (2017-2035)
    10.2 Middle East & Africa CRISPR and Cas Genes Market Size by Type
        10.2.1 Middle East & Africa CRISPR and Cas Genes Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa CRISPR and Cas Genes Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa CRISPR and Cas Genes Market Share by Type (2017-2035)
    10.3 Middle East & Africa CRISPR and Cas Genes Market Size by Application
        10.3.1 Middle East & Africa CRISPR and Cas Genes Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa CRISPR and Cas Genes Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa CRISPR and Cas Genes Market Share by Application (2017-2035)
    10.4 Middle East & Africa CRISPR and Cas Genes Market Size by Country
        10.4.1 Middle East & Africa CRISPR and Cas Genes Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa CRISPR and Cas Genes Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Synthego
        11.1.1 Synthego Company Details
        11.1.2 Synthego Business Overview
        11.1.3 Synthego CRISPR and Cas Genes Introduction
        11.1.4 Synthego Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.1.5 Synthego Recent Developments
    11.2 Thermo Fisher Scientific, Inc.
        11.2.1 Thermo Fisher Scientific, Inc. Company Details
        11.2.2 Thermo Fisher Scientific, Inc. Business Overview
        11.2.3 Thermo Fisher Scientific, Inc. CRISPR and Cas Genes Introduction
        11.2.4 Thermo Fisher Scientific, Inc. Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.2.5 Thermo Fisher Scientific, Inc. Recent Developments
    11.3 GenScript
        11.3.1 GenScript Company Details
        11.3.2 GenScript Business Overview
        11.3.3 GenScript CRISPR and Cas Genes Introduction
        11.3.4 GenScript Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.3.5 GenScript Recent Developments
    11.4 Addgene
        11.4.1 Addgene Company Details
        11.4.2 Addgene Business Overview
        11.4.3 Addgene CRISPR and Cas Genes Introduction
        11.4.4 Addgene Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.4.5 Addgene Recent Developments
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck CRISPR and Cas Genes Introduction
        11.5.4 Merck Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.5.5 Merck Recent Developments
    11.6 Integrated DNA Technologies, Inc.
        11.6.1 Integrated DNA Technologies, Inc. Company Details
        11.6.2 Integrated DNA Technologies, Inc. Business Overview
        11.6.3 Integrated DNA Technologies, Inc. CRISPR and Cas Genes Introduction
        11.6.4 Integrated DNA Technologies, Inc. Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.6.5 Integrated DNA Technologies, Inc. Recent Developments
    11.7 Transposagen Biopharmaceuticals, Inc.
        11.7.1 Transposagen Biopharmaceuticals, Inc. Company Details
        11.7.2 Transposagen Biopharmaceuticals, Inc. Business Overview
        11.7.3 Transposagen Biopharmaceuticals, Inc. CRISPR and Cas Genes Introduction
        11.7.4 Transposagen Biopharmaceuticals, Inc. Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.7.5 Transposagen Biopharmaceuticals, Inc. Recent Developments
    11.8 OriGene Technologies, Inc.
        11.8.1 OriGene Technologies, Inc. Company Details
        11.8.2 OriGene Technologies, Inc. Business Overview
        11.8.3 OriGene Technologies, Inc. CRISPR and Cas Genes Introduction
        11.8.4 OriGene Technologies, Inc. Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.8.5 OriGene Technologies, Inc. Recent Developments
    11.9 New England Biolabs
        11.9.1 New England Biolabs Company Details
        11.9.2 New England Biolabs Business Overview
        11.9.3 New England Biolabs CRISPR and Cas Genes Introduction
        11.9.4 New England Biolabs Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.9.5 New England Biolabs Recent Developments
    11.10 Horizon Discovery Group Co.
        11.10.1 Horizon Discovery Group Co. Company Details
        11.10.2 Horizon Discovery Group Co. Business Overview
        11.10.3 Horizon Discovery Group Co. CRISPR and Cas Genes Introduction
        11.10.4 Horizon Discovery Group Co. Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.10.5 Horizon Discovery Group Co. Recent Developments
    11.11 Cellecta, Inc.
        11.11.1 Cellecta, Inc. Company Details
        11.11.2 Cellecta, Inc. Business Overview
        11.11.3 Cellecta, Inc. CRISPR and Cas Genes Introduction
        11.11.4 Cellecta, Inc. Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.11.5 Cellecta, Inc. Recent Developments
    11.12 Agilent Technologies
        11.12.1 Agilent Technologies Company Details
        11.12.2 Agilent Technologies Business Overview
        11.12.3 Agilent Technologies CRISPR and Cas Genes Introduction
        11.12.4 Agilent Technologies Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.12.5 Agilent Technologies Recent Developments
    11.13 Applied StemCell, Inc.
        11.13.1 Applied StemCell, Inc. Company Details
        11.13.2 Applied StemCell, Inc. Business Overview
        11.13.3 Applied StemCell, Inc. CRISPR and Cas Genes Introduction
        11.13.4 Applied StemCell, Inc. Revenue in CRISPR and Cas Genes Business (2017-2022)
        11.13.5 Applied StemCell, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global CRISPR and Cas Genes Market